Hangzhou Singclean Medical Products Co., Ltd., established in March 2003 with registered capital of 20,000,000 RMB, is a national high and new technology enterprise integrating the R&D, production and sales of medical biomaterials. With well-qualified staff, thorough quality management system and first-class facilities, the company ensures the continuous production of medical devices and drug injection products of Class III that confirm to the laws and regulations of the State Food and Drug Administration (SFDA) and EU MDD.
Sticking to a quality policy of "Quality First, Management Priority, Building a Harmonious Enterprise, and Creating the Singclean Brand", the company passed the ISO9001 quality management system certification and ISO13485 medical devices quality management system certification in 2007, and obtained in 2008 the Innovation Fund Certificate certified by the Ministry of Science and Technology with her MPH hemostatic microspheres project. The company obtained the certification of high and new technology enterprise of Hangzhou in 2007, of Zhejiang Province in 2008, of China in 2010, and her medical sodium hyaluronatethe gels passed the CE certification in 2011.
In addition, the company set up a joint research center with Zhejiang University of Science and Technology, and has well established R & D cooperation relations with Zhejiang University, Donghua University and Zhejiang University of Technology, developing four series of new products with proprietary intellectual property rights, and with a variety of high-tech products to be developed cooperatively. The company also built an R & D platform for medical biomaterials that keeps up with the international level, and made major breakthrough in many key technologies such as those for stopping bleeding, anti-adhesion, and tissue engineering basic materials, with five patents obtained and a number of products applying for the patents.
Committing herself to develop new types of composite and smart biomaterials, the company majors in producing biodegradable bio-materials and their derivatives, and has at present products of 7 series (chitosan, medical sodium hyaluronate gels, cross-linked hyaluronic acidsodium gels, microporous polysaccharide, oxidized regenerated cellulose, basic materials of tissue engineering, in vitro diagnostic reagents), 50 varieties, being sold in 30 provinces and cities across the country, with users totaled more than 1,000 and annual sales approaching RMB 200 million Yuan. Moreover, some of the products are exported to over 20 countries around the world, such as Italy, Russia, Indonesia, Turkey, Australia, and France.
Sticking to the enterprise development spirit that stresses “doing step by step for sustainable development”, the company commits herself to be the leading suppliers of medical biomaterials with the most varieties of products in China.